HLA-DRA Antibody Blocking peptide
HLA-DRA Antibody Blocking peptide
Product Specifications
Product Name Alternative
HLA class II histocompatibility antigen, DR alpha chain, MHC class II antigen DRA, HLA-DRA, HLA-DRA1
UniProt
P01903
Field of Research
Cell Biology
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1925237 was selected from the N-term region of human HLA-DRA. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6232543-01 0.1 mL
DND1 (RBMS4, Dead End Protein Homolog 1, RNA-binding Motif, Single-stranded-interacting Protein 4, MGC34750) (MaxLight 750)
Sign In for Pricing
View Details MBS6232543-02 5x 0.1 mL
DND1 (RBMS4, Dead End Protein Homolog 1, RNA-binding Motif, Single-stranded-interacting Protein 4, MGC34750) (MaxLight 750)
Sign In for Pricing
View Details 